Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Antineoplastic Protein Synthesis Inhibitors: Drug Class, Uses, Side Effects, Drug Names

HOW DO ANTINEOPLASTIC PROTEIN SYNTHESIS INHIBITORS WORK? Antineoplastic protein synthesis inhibitors are a class of drugs used to treat adults with chronic or accelerated phase chronic myeloid leukemia (CML; a type of cancer of the white blood cells) who have

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

HOW DO ANTINEOPLASTIC PROTEIN SYNTHESIS INHIBITORS WORK?

Antineoplastic protein synthesis inhibitors are a class of drugs used to treat adults with chronic or accelerated phase chronic myeloid leukemia (CML; a type of cancer of the white blood cells) who have already been treated with at least two other medications for CML and can no longer benefit from these medications or cannot take these medications because of side effects. CML is a rare, slow-growing type of cancer of the bone marrow—the spongy tissue inside bones where blood cells are made. CML causes an increased number of white blood cells in the blood. Signs and symptoms may include:

  • Bone pain
  • Easy bleeding
  • Feeling full after eating a small amount of food
  • Feeling exhausted or tired
  • Fever
  • Weight loss without trying
  • Loss of appetite
  • Pain or fullness below the ribs on the left side
  • Excessive sweating during sleep (night sweats)

The only drug belonging to this class is “omacetaxine” synthesized from cephalotaxine, which is an extract from the leaves of the plant, Cephalotaxus species. Protein synthesis inhibitor works by slowing down or stopping the growth or proliferation of cells by disrupting the processes that lead directly to the generation of new proteins.

Protein synthesis inhibitors are administered as a liquid to be injected under the skin in the thigh or stomach area typically twice a day for 7 to 14 days.

Protein synthesis inhibitors work in the following ways:

They inhibit different stages of translation of the bacterial mRNA into proteins.

This inhibition is a result of interruption of peptide chain elongation, blocking the “A” site of ribosomes and misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.

HOW ARE ANTINEOPLASTIC PROTEIN SYNTHESIS INHIBITORS USED?

Antineoplastic protein synthesis inhibitors are indicated for the treatment of chronic or accelerated phase chronic myeloid leukemia with resistance and/or intolerance to two or more tyrosine kinase inhibitors.

WHAT ARE SIDE EFFECTS OF ANTINEOPLASTIC PROTEIN SYNTHESIS INHIBITORS?

Some of the common side effects include:

  • Nausea
  • Vomiting
  • Constipation
  • Diarrhea
  • Abdominal pain
  • Headache
  • Tiredness/weakness
  • Joint/back pain
  • Loss of appetite
  • Pain, redness, swelling, hardness, or itching at the injection site

Other rare side effects include:

  • Dizziness
  • Fatigue
  • Hair loss
  • Anemia (low red blood cell count)
  • Insomnia
  • Shortness of breath
  • Chills, sore throat, fever, or cough
  • Thrombocytopenia (low blood platelet count)
  • Peripheral edema (swelling of lower legs or hands)
  • Epistaxis (bleeding from the nose)
  • Hyperglycemia (high blood glucose level)

Information contained herein is not intended to cover all possible side effects, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Check with your doctor or pharmacist to make sure these drugs do not cause any harm when you take them along with other medicines. Never stop taking your medication and never change your dose or frequency without consulting your doctor.

From

https://www.rxlist.com/synribo-drug.htm#description

https://www.webmd.com/drugs/2/drug-162890/omacetaxine-subcutaneous/details

https://medlineplus.gov/druginfo/meds/a613012.html

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Could you discuss any ongoing or future research projects that you are particularly excited about in the field of axon biology and sncRNAs?

Certainly. We're keenly exploring extracellular vesicles as mediums for cells to communicate. These cell made vesicles often carry microRNAs and other non-coding RNAs, presenting a unique avenue to understand how neurons modulate their environment, which is especially interesting in neurological conditions. We are exploring extracellular vesicles as these tools with which cells can communicate and transfer gene expression patterns. And we're looking at, for example, how early life brain tumours such as medulloblastoma can impact neuron development and activity and how this can affect later life pain processing and neurological conditions. This has been possible via funding from the Medical Research Foundation, which supported a big collaboration between the labs of Gareth Hathway, Beth Coyle, Vicky James, Anna Grabowska and myself in Nottingham.

Source: www.news-medical.net ↗
comparison

Local vs Systemic IGF-1: The Research Design Implication

A key experimental consideration in IGF-1 LR3 research is the distinction between local intramuscular injection (mimicking locally produced muscle IGF-1) and systemic administration (mimick…

Source: peptideslabuk.com
Research context

Read sources and limitations before applying a claim.

Sermorelin and Muscle Research: GHRH Analogue Biology, Skeletal Muscle Protein Synthesis and Myofibre Hypertrophy Mechanisms UK 2026

This article is written for academic and scientific research purposes only. Sermorelin is a Research Use Only (RUO) compound not approved for human therapeutic use in the United Kingdom outside licensed clinical contexts. All experimental protocols, dosing references and mechanistic data cited here relate exclusively to preclinical and in vitro research models. Nothing in this article constitutes medical advice, clinical guidance or encouragement of self-administration.

Source: peptideslabuk.com ↗

Studies of Chonluten Peptide in Protein Synthesis and Inflammation Reduction

by Dr. Usman | Sep 7, 2022 | Research Contents: Tripeptides in Bioregulatory Processes Chonluten and Gene Expression in the Lungs Chonluten and the Gastrointestinal Tract References Featured Product

Source: biotechpeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →